NYU Langone receives grant to study colorectal cancer
Apr 07, 2021 | 255 views | 0 0 comments | 11 11 recommendations | email to a friend | print
Communities of color are disproportionately affected by colorectal cancer, with Black men and women 20 percent more likely to get the disease than other groups and 40 percent more likely to die from it, according to the American Cancer Society.

Thanks to a $2.2 million grant from the Steven & Alexandra Cohen Foundation, NYU Langone Health is expanding its program to address this disparity in Brooklyn.

“Early screening is a proven way to prevent colorectal cancer,” said Dr. Mark Pochapin, the Sholtz/Leeds Professor of Gastroenterology and director of the Division of Gastroenterology and Hepatology in NYU Langone’s Department of Medicine. “Even young and seemingly healthy people can be victims of colorectal cancer, and we truly hope to build awareness around the importance of screening within at-risk communities while providing additional opportunities for early detection.”

The grant will support an early intervention program in Brooklyn that can lead to better outcomes for gastrointestinal diseases and cancers. To detect colorectal cancer early, experts at NYU Langone recommend all adults with average risk, regardless of race, start screening at age 45 to 50.

Screening is recommended for all Black men and women beginning at age 45, regardless of risk profile, because of the higher incidence of disease and death. Through seamless integration with NYU Langone’s Perlmutter Cancer Center, suspicious findings can be diagnosed and treated quickly and closer to home at Perlmutter Cancer Center–Sunset Park.

The gift will also support increased screening capacity at NYU Langone Hospital–Brooklyn and the Brooklyn Endoscopy and Ambulatory Surgery Center, with a specific focus on reaching underserved communities.

Additionally, a portion of the funds will expand screening for liver disease with support from Dr. Saikiran Kilaru, clinical assistant professor in NYU Langone’s Department of Medicine Division of Gastroenterology and Hepatology, and backs the recruitment of an epidemiology expert to research efforts on risk factors, screening, quality indicators, and prevention of colorectal cancer.

“Colorectal cancer disparities are of critical concern, so we are eager to support NYU Langone’s efforts to increase cancer screenings and expand care in these underserved communities,” says Alex Cohen, president of the Steven & Alexandra Cohen Foundation.
Comments-icon Post a Comment
No Comments Yet